Pipeline and Commercial Insight: Obesity - the 11 billion market that never was

Author: Bharat Book Bureau

Author: Bharat Book Bureau

Pipeline and Commercial Insight: Obesity - the 11 billion market that never was

The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise: $513.7m sales in 2008 fall far short of analyst predictions. ( http://www.bharatbook.com/detail.asp?id=129379&rt=Pipeline-and-Commercial-Insight-Obesity-the-11-billion-market-that-never-was.html )

Scope of this research

Defining the key clinical characteristics of the obesity sector that present a unique commercial challenge

Translation of critical clinical and regulatory issues into pertinent practical considerations for both incumbent players and new market entrants

Clinical and commercial analysis of existing and late stage products targeting the sector, qualified by key opinion leader interviews

Seven major market forecasts for key products to 2018

Research and analysis highlights

The 125 million obese adults in 2008 across the US, Japan, France, Germany, Italy, Spain and UK will grow to at least 143 million by 2018. If just 25% of these adults were treated for one year with a dollar per day product, achieving 80% compliance rates, market potential would rise from $8.6 billion in 2008 to $10.5 billion in 2018

There may be some advantages to exploring head-to-head trials of existing therapies, the combination use of drugs or demonstrating longer term improvements to cardiovascular risks, but in the current environment this is unlikely to expand the proportion of the obese population in which existing and late stage pipeline products will be used.

GSK's Alli failed to sustain US launch sales, Sanofi-Aventis' Acomplia has been withdrawn. 27 clinical pipeline products discontinued between publication of this report and its predecessor (2006) have cost at least $1.1 billion in trial costs alone. Some developers will be facing administration or liquidation rather than arranging partnering deals.

Key reasons to purchase this research

* Understand why predictions for this market have been repeatedly over-stated

* Qualify market expectations against the practicalities of targeting this unyielding market

* Assess the qualities of marketed and pipeline products and their commercial handling to determine their realistic prospects To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=129379&rt=Pipeline-and-Commercial-Insight-Obesity-the-11-billion-market-that-never-was.html

Or

Contact us at :

Bharat Book Bureau

Tel: +91 22 27578668

Fax: +91 22 27579131

Email: info@bharatbook.com

Website: www.bharatbook.com

Blog: http://bharatbookresearch.blogspot.com

Follow us on twitter: http://twitter.com/3bbharatbookAbout the Author:

We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com

POST COMMENT

Obesity Market Forecast An In-depth View On Obesity Overview of Obesity Obesity Surgery Reduced Cost Reductil – The one a day weight loss pill that fights obesity with effective ease Easy Ways To Recover From Obesity Is Liposuction An Appropriate Treatment For Obesity? Some Important Facts About Obesity Can Liposuction Treat Obesity? Liposuction Is Not A Solution For Childhood Obesity What Are The Causes of Childhood Obesity? An Overview to Childhood Obesity and Its Causes Speeding Up Metabolism Gets The Job Done